Probiota Asia 2019

Flavonoid-rich diet and beneficial bacteria attributed to low colorectal cancer in Indian population – Gut microbiome study

By Guan Yu Lim

- Last updated on GMT

Dr. Vineet Sharma from the Indian Institute of Science Education and Research speaking at Probiota Asia 2019
Dr. Vineet Sharma from the Indian Institute of Science Education and Research speaking at Probiota Asia 2019

Related tags Probiota Asia Colorectal cancer India Flavonoid

Researchers from India have discovered that a diet high in flavonoids may contribute to the low prevalence of colorectal cancer (CRC) in the Indian population.

At our Probiotia Asia event held in Singapore, Dr. Vineet Sharma from the Indian Institute of Science Education and Research (IISER) said CRC was the third most common cancer and second leading cause of cancer death globally, “but surprisingly lower in India, (which is) attributed to high flavonoid consumption​.”

Despite this, he stressed that CRC risk was on the rise in India, due to the growing adoption of a Western lifestyle and lack of physical activity.

Acting on the lack of early detection techniques for CRC, Sharma and his team conducted India’s first CRC microbiome and metabolome study.

Study findings

The study recruited both CRC patients (early to late stages of cancer) and healthy individuals to compare a diseased gut metagenome with a healthy one.

The study found an association of bacteroides and other bacterial taxa in the faeces of the CRC group.

The researchers then constructed a gene catalogue and metabolome for colorectal cancer and found 33 gene markers and 20 taxonomic markers, which could be used to diagnose CRC.

There was also microbiome dysbiosis in CRC patients. Dysbiosis is the disruption of the normal microbiome content leading to a reduction in pathways related to the biosynthesis of six essential amino acids (Leucine, Isoleucine, Lysine, Phenylalanine, Tryptophan and Valine) out of the nine essential amino acids the body requires.

From this, researchers said these cohort-specific biomarkers could be used in non-invasive diagnosis of CRC, from faecal samples alone.

Sharma said: “When we use these markers, it can clearly segregate the CRC patients and healthy individuals​.”

Flavonoid degradation

According to him, the typical Indian diet is rich in flavonoids, which can be found in tea, coffee, terminalia bark, fenugreek seeds, mustard seeds, cinnamon, red chili powder, cloves, and turmeric.

He explained that flavonoids have a role to play in the prevention of cancer, CVD, type 2 diabetes and other diseases.

But, the presence of certain gut bacteria can degrade these flavonoids by cleaving the C-ring of the flavonoid molecules.

For instance, in the group with CRC, bacteria such as veillonella parvula, bacteroides fragilis​ were present, where other research have found its possible role in inducing epithelial cell changes and modulate the mucosal immune responses, resulting in CRC progression.

However, in the group without CRC earlier, faecal samples showed higher levels of prevotella​ bacteria compared to the CRC.

The abundance of prevatolla​ is attributed to a diet higher in plant materials and carbohydrate. We reported this earlier​ when researchers from IISER conducted the largest gut microbiome study of the Indian population.

The degradation of beneficial flavonoids thus play an important role in cancer progression in the Indian cohort.

Indian-specific probiotics

Sharma said the Indian gut microbiome was uniquely different from other parts in the world due to its lifestyle, food habits, and a large population of vegetarians.

He said these findings provide motivation to develop Indian-specific probiotics, which can therapeutically target intestinal microbiome by promoting beneficial bacteria and inhibiting potentially pathogenic species.

He also added that most probiotic bacteria were imported from other countries, with the top companies in the Indian market being Amul, Nestle, Mother Dairy and Yakult.

He reiterated that the Indian population needed a probiotic that was specially designed for the Indian gut microbiome.

Related news

Show more

Related products

show more

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Taking Immune Support to a New Level

Taking Immune Support to a New Level

Content provided by AB Biotek Human Nutrition & Health | 30-Oct-2023 | White Paper

Patent-pending ABB C1® redefines immune support by addressing innate, acquired, and Trained Immunity. In 'ABB C1®: Training Now for Future Immune...

Full Vegan Protein Ingredients Solution

Full Vegan Protein Ingredients Solution

Content provided by Ingredients4u AG | 24-Jul-2023 | Product Brochure

Plant-based products have always been a hot topic in the market, the plant-based food market was valued at $29.4 billion in 2020.

Follow us


View more


Nutra Champions Podcast

Nutra Champions Podcast